CBI’s Compliance Congress for Specialty Products serves as the life sciences industry’s only conference catered to the unique compliance challenges for specialty bio/pharmaceutical companies, pre- and post-commercialization. This conference offers proactive strategies for managing risks in patient support services, specialty pharmacy contracting and government price reporting.
To learn more, click here.
"Shed Light on Regulatory and Compliance Concerns for Specialty Pharmacy Distribution"
Day 1 - September 13 @ 3:30 pm
Michelle D. Axelrod
Principal, Porzio, Bromberg & Newman, PC;
Vice President, Porzio Life Sciences, LLC
Senior Director, Legal
"Explore the Trends in Drug Pricing Legislation and Other State Initiatives"
Day 2 - September 14 @ 9:15 am
John P. Oroho
Executive Vice President & Chief Strategy Officer
Porzio Life Sciences, LLC